Beverage supplier Hey Song Corp (黑松) is planning to tap into the carbonated drink market in Southeast Asia with its high value-added products over the coming years, in line with the government’s New Southbound Policy, a company executive said yesterday.
“We are upbeat that some of our key products are very likely to grab market share [in the region’s soft drink market],” Hey Song chairman Chang Pin-tang (張斌堂) told an investors’ conference in Taipei, referring to the company’s carbonated drinks containing vitamin C.
As part of its three-year renovation project, the company has allocated more than NT$2.2 billion (US$73.32 million) to build a new aseptic processing line, which would allow it to take advantage of growing health consciousness by adding nutrients to soft drinks.
Hey Song must provide this type of differentiated product to compete with well-known global brands in Southeast Asian markets, Chang said, adding that the company is targeting the Philippines, Thailand and Singapore.
The 92-year-old beverage maker did not disclose its investment budget or timetable for the ongoing Southeast Asia project, but said it is in talks with some Taiwanese firms that have had roots in the region for a long time.
Hey Song, which has a solid 7 percent share of Taiwan’s drink market, posted a net profit of NT$453.04 million, or earnings per share of NT$1.13, for the first three quarters of this year, which represented a decline of 54.68 percent year-on-year from NT$999.54 million.
The profitability of its core business did not decline significantly, the company said, attributing the sharp dip to a relatively higher comparison base in the same period last year, when it booked a one-off gain from the sale of its Chinese subsidiary.
The company sold its Suzhou-based unit, which contributed a non-operating gain of nearly NT$500 million in the second quarter of last year, company vice president Pai Chin-wen (白錦文) told investors.
Sales in the first three quarters of this year amounted to NT$7.05 billion, a 6.3 percent increase from NT$6.63 billion from the previous year, while operating income grew 9.06 percent to NT$156.16 million from NT$143.19 million.
Soft drinks made up 56 percent of the company’s total revenue, while alcohol contributed the remaining 44 percent.
Hey Song has distribution contracts with Kinmen Kaoliang Liquor Inc (金門高粱), Japan’s Choya Umeshu Co and French cognac maker Remy Martin, company data showed.
The company’s stock price yesterday remained unchanged at NT$31.1 in Taipei trading.
UNCONVINCING: The US Congress questioned whether the company’s Chinese owners pose a national security risk and how the app might influence young users TikTok chief executive officer Shou Chew (周受資), confronted with an unforgiving, distrustful US Congress, tried to give answers in his testimony on Thursday that avoided offending either the US government or China. However, his evasiveness left Congress unsatisfied, with representatives hungrier than ever to punish TikTok for ties to its parent company ByteDance Ltd (字節跳動), based in Beijing. He did not bring his company any closer to a resolution. Politically, TikTok is in a tougher spot. Its executives had been discussing divesting from ByteDance to resolve US national security concerns, people familiar with the matter told Bloomberg. However, China this week said
The Investment Commission yesterday approved a Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) application to invest an additional US$3.5 billion in its Arizona subsidiary to manufactured advanced chips. The world’s largest contract chipmaker’s board of directors last month approved the funding project after TSMC started moving manufacturing equipment into the fab in December last year in preparation for the production of 4-nanometer chips next year. TSMC said it has also commenced the second phase of facility construction in Arizona. The second fab is to produce semiconductors using 3-nanometer technology in 2026. Altogether, TSMC plans to spend US$40 billion on the Arizona fabs, doubling its
Microsoft Corp has threatened to cut off access to its Internet search data, which it licenses to rival search engines, if they do not stop using it as the basis for their own artificial intelligence (AI) chat products, people familiar with the dispute have said. The software maker licenses the data in its Bing search index — a map of the Internet that can be quickly scanned in real time — to other companies that offer Web search, such as Apollo Global Management Inc’s Yahoo and DuckDuckGo. Last month, Microsoft integrated a cousin of ChatGPT, OpenAI’s AI-powered chat technology, into Bing. Rivals
Sanofi SA’s drug Dupixent succeeded in a late-stage trial for chronic obstructive pulmonary disease (COPD), raising the odds that the blockbuster would be the first biologic medicine cleared to treat the lung disorder. Dupixent, which is already prescribed for asthma and some skin conditions, showed a 30 percent reduction in the rate at which patients’ COPD worsened compared with those who received a placebo during the stage-three Boreas trial, the company said in a statement yesterday. The positive data could herald a new era of cutting-edge treatments for the life-threatening respiratory affliction and provide another major boost in demand for the French